VRDN

Viridian Therapeutics, Inc.\DE · Healthcare · Market cap $2.4B

Insiders sold $348K net in the last 90 days ·1 seller, 0 buyers· latest Form 4 filed Aug 21, 2026

Insider Buying

$30.0M

reported purchases (SEC code P)

Insider Selling

$419K

reported sales (SEC code S)

Unique Insiders

2

in the rolling window

Latest filing

Aug 21, 2026

Tousignant Jennifer

Viridian Therapeutics, Inc.\DE (VRDN) has 13 SEC Form 4 filings (19 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Aug 21, 2026.

Inside the rolling window, 2 insiders at Viridian Therapeutics, Inc.\DE reported 2 open-market purchases totaling $30.0M and 2 open-market sales totaling $419K. Insiders have net bought $19.7M over the trailing 6 months. The largest single insider purchase in this window was $20.0M by Director, 10% Owner Fairmount Funds Management LLC on May 11, 2026. The most recent open-market filing is a sale of 14,212 shares by Chief Legal Officer Tousignant Jennifer, dated Aug 19, 2026, worth $348K.

  • Industry:Biotechnology
  • CEO:Stephen F. Mahoney
  • Employees:252
  • HQ:Waltham, MA, US
  • IPO:2014-06-18
Source
Tousignant JenniferFirst in 8 months
Sale$348KAug 21SEC ↗
Purchase$20.0MMay 13SEC ↗
Sale$71KJan 2SEC ↗
Purchase$10.0MOct 27SEC ↗
Showing 1–4 of 4
1 / 1

Earnings: last 7 quarters

EstimatedActual

Frequently asked questions

How many SEC Form 4 insider filings does VRDN have?

Viridian Therapeutics, Inc.\DE (VRDN) has 13 SEC Form 4 filings (19 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Aug 21, 2026.

When was the most recent SEC Form 4 filing for VRDN?

The most recent Form 4 filing for VRDN on Tracefour is dated Aug 21, 2026.

What is the net insider flow at VRDN over the last 6 months?

Over the trailing 180 days, insiders at VRDN have net bought $19.7M based on SEC Form 4 disclosures.

What was the largest insider purchase at VRDN?

The largest single insider open-market purchase at VRDN in the rolling window was $20.0M by Director, 10% Owner Fairmount Funds Management LLC on 2026-05-11.

What is the total insider buy and sell value at VRDN in the current window?

Inside the rolling window, insiders at VRDN bought $30.0M and sold $419K based on SEC Form 4 filings.

Can I get alerts for VRDN insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Viridian Therapeutics, Inc.\DE (VRDN). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

Viridian Therapeutics, Inc.\DE is in the Healthcare sector.